MRK vs IDXX
By Alex · Tickerpine
Merck & Co., Inc. vs IDEXX Laboratories, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | IDXX |
|---|---|---|
| Price | $145.27 | $560.38 |
| Market cap | $358.41B | $44.15B |
| P/E ratio | 117.2 | 39.4 |
| ROE | 6.96% | 74.21% |
| Profit margin | 4.77% | 25.03% |
| Revenue growth | 5.10% | 9.70% |
| Dividend yield | 2.34% | 0.00% |
| Beta | 0.22 | 1.55 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs IDXX in plain English
- MRK is the bigger company — about 8.1× the market cap of IDXX.
- IDXX is cheaper on earnings (P/E 39.4 vs 117.2).
- IDXX earns a higher return on equity (74% vs 7%).
- IDXX is growing revenue faster (10% vs 5%).
- MRK pays a dividend (2.34%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
IDXX return calculator
See what $1,000 in IDEXX Laboratories, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.